Kyle Mikson
Stock Analyst at Canaccord Genuity
(2.06)
# 3,098
Out of 5,008 analysts
91
Total ratings
38.67%
Success rate
-4.04%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GRAL GRAIL | Maintains: Buy | $43 → $75 | $62.82 | +19.39% | 3 | Oct 3, 2025 | |
| GH Guardant Health | Maintains: Buy | $65 → $75 | $63.44 | +18.22% | 8 | Sep 26, 2025 | |
| BDSX Biodesix | Maintains: Buy | $30 → $20 | $7.30 | +173.97% | 5 | Sep 19, 2025 | |
| QSI Quantum-Si incorporated | Maintains: Hold | $1 | $1.77 | -43.50% | 4 | Sep 9, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $37 | $22.93 | +61.36% | 5 | Sep 9, 2025 | |
| QTRX Quanterix | Downgrades: Hold | $12 → $5 | $5.66 | -11.66% | 7 | Aug 11, 2025 | |
| ILMN Illumina | Maintains: Hold | $99 → $105 | $96.68 | +8.61% | 12 | Aug 1, 2025 | |
| XGN Exagen | Maintains: Buy | $8 → $11 | $10.96 | +0.36% | 4 | Jul 30, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $18 → $15 | $11.60 | +29.31% | 8 | May 12, 2025 | |
| RGEN Repligen | Maintains: Hold | $170 → $150 | $145.93 | +2.79% | 3 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.40 | +114.29% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $195 | $168.53 | +15.71% | 8 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.05 | +185.71% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $75 | $57.75 | +29.87% | 9 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.65 | +207.69% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $0.49 | +10,031.80% | 1 | Mar 30, 2021 |
GRAIL
Oct 3, 2025
Maintains: Buy
Price Target: $43 → $75
Current: $62.82
Upside: +19.39%
Guardant Health
Sep 26, 2025
Maintains: Buy
Price Target: $65 → $75
Current: $63.44
Upside: +18.22%
Biodesix
Sep 19, 2025
Maintains: Buy
Price Target: $30 → $20
Current: $7.30
Upside: +173.97%
Quantum-Si incorporated
Sep 9, 2025
Maintains: Hold
Price Target: $1
Current: $1.77
Upside: -43.50%
Castle Biosciences
Sep 9, 2025
Maintains: Buy
Price Target: $37
Current: $22.93
Upside: +61.36%
Quanterix
Aug 11, 2025
Downgrades: Hold
Price Target: $12 → $5
Current: $5.66
Upside: -11.66%
Illumina
Aug 1, 2025
Maintains: Hold
Price Target: $99 → $105
Current: $96.68
Upside: +8.61%
Exagen
Jul 30, 2025
Maintains: Buy
Price Target: $8 → $11
Current: $10.96
Upside: +0.36%
10x Genomics
May 12, 2025
Maintains: Buy
Price Target: $18 → $15
Current: $11.60
Upside: +29.31%
Repligen
Apr 16, 2025
Maintains: Hold
Price Target: $170 → $150
Current: $145.93
Upside: +2.79%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $1.40
Upside: +114.29%
Feb 28, 2025
Maintains: Buy
Price Target: $180 → $195
Current: $168.53
Upside: +15.71%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.05
Upside: +185.71%
Nov 6, 2024
Maintains: Buy
Price Target: $95 → $75
Current: $57.75
Upside: +29.87%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.65
Upside: +207.69%
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $0.49
Upside: +10,031.80%